Incontinence therapy (Algos)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIncontinence therapy (Algos)
Drug Alias Nameincontinence therapy (NMDA antagonists)
ClassificationBiologics
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsUrinary Incontinence, StressUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndo International Plc
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence, StressUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksN/A